C16 Biosciences, the biotech startup focused on developing an alternative to palm oil, has raised $20M in Series A funding from investors that include Y Combinator, Data Collective DCVC, AME Cloud Ventures, Liquid 2 Ventures, Sound Ventures, Breakthrough Energy Ventures, Future Tech Lab, and Waldencast. Founded by David Heller, Harry McNamara, and Shara Ticku in 2017, C16 Biosciences has now raised a total of $24M in reported equity funding.
The AlleyWatch audience is driving progress and innovation on a global scale. With its regional media properties, AlleyWatch serves as the highway for technology and entrepreneurship. There are a number of options to reach this audience of the world’s most innovative organizations and startups at scale including having prominent brand placement in a high-visibility piece like this, which will be read by the vast majority of key influencers in the New York business community and beyond. Find out more here.